97. The 31st Session of the CCFAC meeting requested Norway to finalize the Position Paper on Zearalenone for consideration at its next Session.[53]
98. The Committee thanked the delegation of Norway for its efforts, and agreed that it would finalize the position paper based on discussions at the present session as a potential basis for future work, with the request that any suggested revisions to the text should be submitted directly to Norway.
